anpac_logo_full color_stacked.png
AnPac Bio Granted a New US patent on Novel Medical Device for Multi-Cancer Detection
01 févr. 2021 07h30 HE | Anpac Bio, USA
SAN JOSE, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
22157.jpg
Global Cervical Cancer Diagnostic Testing Devices Pipeline Assessment 2020: Developments, Products, Company Product Overview, Recent Developments
24 déc. 2020 05h18 HE | Research and Markets
Dublin, Dec. 24, 2020 (GLOBE NEWSWIRE) -- The "Cervical Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering. "Cervical...
anpac_logo_full color_stacked.png
AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases
14 déc. 2020 07h30 HE | Anpac Bio, USA
SAN JOSE, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United...
anpac_logo_full color_stacked.png
Anpac Bio Announces Change of Auditor
04 déc. 2020 16h01 HE | Anpac Bio, USA
SAN JOSE, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States...
22157.jpg
Outlook on the Breast Cancer Screening Market in Europe to 2027 - Growing Initiatives for Breast Cancer Management is Driving Growth
04 déc. 2020 09h03 HE | Research and Markets
Dublin, Dec. 04, 2020 (GLOBE NEWSWIRE) -- The "Europe Breast Cancer Screening Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Test Type , End User , and Country" report has been...
anpac_logo_full color_stacked.png
AnPac Bio Sets Record Test Volume in Q3, and Forecasts ~ 100% Revenue Growth in 2020
25 nov. 2020 07h30 HE | Anpac Bio, USA
SAN JOSE, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
anpac_logo_full color_stacked.png
Anpac Bio Announces Appointment of New Independent Director
16 nov. 2020 16h01 HE | Anpac Bio, USA
SAN JOSE, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
22157.jpg
Insights on the Breast Cancer Screening Market in North America to 2027 - by Test Type, End-user and Countries
05 nov. 2020 08h53 HE | Research and Markets
Dublin, Nov. 05, 2020 (GLOBE NEWSWIRE) -- The "North America Breast Cancer Screening Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Test Type; End User, and Countries" report has...
anpac_logo_full color_stacked.png
Anpac Bio Completes Over 200,000 Biophysics Based Cancer Detection Tests, With Data Covering Close to 60 Types of Cancer
26 oct. 2020 06h45 HE | Anpac Bio, USA
SAN JOSE, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United...
anpac_logo_full color_stacked.png
AnPac Bio to Receive Up To USD $8 Million Dollar Grants and Award for R&D, Product Commercialization, and Milestone Achievements
07 oct. 2020 07h00 HE | Anpac Bio, USA
SAN JOSE, Calif., Oct. 07, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...